GSK Makes I-O Move With Merck KGaA Deal Worth Up To €3.7bn

 
• By Kevin Grogan
Brainstorming
Merck KGaA and GSK See Bright Future For M7824 • Source: Shutterstock

More from Immuno-oncology

More from Anticancer